ADRB2 and hepatocellular carcinoma: As expected, YB-1 was pulled down in metastatic HCC specimens and SMMC-7721 cell lysates pre-treated with 10 μM ISO with an anti-β2-AR antibody, and β2-AR was pulled down with an anti-YB-1 antibody (Fig. 2a, b).